
Opinion|Videos|January 7, 2026
Closing Thoughts from the Experts
This final segment consists of expert clinicians offering key takeaways to help pharmacists prepare for potential approvals and integrate new TNBC therapies into practice.
Advertisement
Episodes in this series

An expert pharmacist and physician offer their main takeaways from the recent clinical trial data in TNBC. Clinical pearls for pharmacists are offered that will help prepare them for potential approval of these pharmacotherapies.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Trending on Pharmacy Times
1
FDA Grants National Priority Vouchers to Enlicitide Decanoate, Sacituzumab Tirumotecan
2
Beyond Injections: Orforglipron and the Future of Oral GLP-1 Receptor Agonist Therapy
3
Toothpaste Tablets Are Gaining Popularity—Here’s Where Pharmacists Fit In
4
Surveys Find Significant Gaps in Public’s Understanding of Shared Decision-Making on Vaccinations
5












































































































































































































